Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AventaCell is a global leader in the development of advanced human tissue-derived products—especially human platelet lysate—for use as animal serum-free supplements in cell culture media. Their UltraGRO™ GMP PRT product has regulatory recognition including a US FDA Type II Drug Master File (DMF), Japan PMDA certificate, and compliance with European Pharmacopoeia standards[9]. The company’s products support the expansion of mesenchymal stem cells and immune cells for translational research in regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AventaCell BioMedical.